Algernon Pharmaceuticals Inc (AGNPF)

[tcm55]

yes, the COVID phase 2 Ifenprodil CT was a 'study' encouraged by the modified standards that we still see for this disease.
We all bought tickets.

As seen in recently posted blogs the data was not bad but the decision needed to be made during the lull before Delta and omicron. BP also was entering the area after their vaccine success. So...?...

The data collected is still viable and pertinent to their application for Ifenprodil SCLC and pancreatic Clinical Trials, IMO. Safety issues were nil.
I expect/hope for AGN to announce progress with the US FDA about these soon, IMO.


BTH/NASH>AGN. The CSO-(NASH) et al determined to moved Ifenprodil forward first with the IPF/CC combo. Yost-UF stuff excited me due to FAIMS. More than half my investment here is BLO $ from the Pot boom days.

Buy, Hold or sell are our options. $30? +-?
...GLTA...


The Uk is suffering with the COVID issue and apparently has an increase in Stroke patients directly related to COVID. There may be considerable support for this treatment from the more realistic and open EU community, I hear.
(lucy in the skys with diamonds)...LOL...